Ionis Pharmaceuticals
(IONS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IONS | UTHR | NBIX | ||
| Company | Ionis Pharmaceuticals | United Therapeutic | Neurocrine Bioscienc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 84.51 | 480.66 | 136.46 | ||
| High | 86.74 | 487.33 | 141.45 | ||
| Low | 82.89 | 476.95 | 136.46 | ||
| Latest | 83.48 | 478.93 | 137.93 | ||
| Change | -1.51 | -3.66 | +0.07 | ||
| % Change | -1.78% | -0.76% | +0.05% | ||
| Volume | 2,677,700 | 432,700 | 1,272,900 | ||
| 20-Day Average Volume | 2,379,930 | 343,630 | 1,078,065 | ||
| Previous Close | 84.99 | 482.59 | 137.86 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 81.11 | 474.71 | 135.52 | ||
| 20-Day Raw Stochastic | 74.00% | 47.59% | 71.33% | ||
| 20-Day Relative Strength | 56.97 | 50.28 | 48.11 | ||
| Weighted Alpha | +126.39 | +34.38 | +12.49 | ||
| Today's Opinion | 100% Buy | 56% Buy | 8% Buy | ||
| Previous Opinion | 100% Buy | 56% Buy | 8% Buy | ||
| Last Month's Opinion | 100% Buy | 96% Buy | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.48% since 01/29/26 | +2.40% since 01/29/26 | -0.02% since 01/29/26 | ||
| Low | 81.90 on 02/02/26 | 462.02 on 01/30/26 | 134.96 on 01/30/26 | ||
| High | 86.74 on 02/05/26 | 487.50 on 02/04/26 | 141.45 on 02/05/26 | ||
| 1-Month | |||||
| %Chg | +6.30% since 01/05/26 | -2.20% since 01/05/26 | +1.43% since 01/05/26 | ||
| Low | 74.20 on 01/20/26 | 455.63 on 01/20/26 | 129.17 on 01/20/26 | ||
| High | 86.74 on 02/05/26 | 512.73 on 01/06/26 | 142.15 on 01/07/26 | ||
| 3-Month | |||||
| %Chg | +11.78% since 11/05/25 | +7.04% since 11/05/25 | -10.29% since 11/05/25 | ||
| Low | 66.66 on 11/10/25 | 444.04 on 11/07/25 | 129.17 on 01/20/26 | ||
| High | 86.74 on 02/05/26 | 519.99 on 12/23/25 | 160.18 on 12/08/25 | ||
| 6-Month | |||||
| %Chg | +93.91% since 08/05/25 | +57.12% since 08/05/25 | +7.43% since 08/05/25 | ||
| Low | 40.03 on 08/07/25 | 292.34 on 08/12/25 | 123.67 on 08/08/25 | ||
| High | 86.74 on 02/05/26 | 519.99 on 12/23/25 | 160.18 on 12/08/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 13,766,169 | 20,778,874 | 13,745,470 | ||
| Shares Outstanding, K | 161,974 | 43,057 | 99,706 | ||
| Annual Sales | 705,140,000 | 2,877,400,000 | 2,355,300,000 | ||
| Annual Net Income | -453,900,000 | 1,195,100,000 | 341,300,000 | ||
| Last Quarter Sales | 156,720,000 | 799,500,000 | 794,900,000 | ||
| Last Quarter Net Income | -128,610,000 | 338,700,000 | 209,500,000 | ||
| 60-Month Beta | 0.29 | 0.85 | 0.31 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.61 on 10/29/25 | 7.16 on 10/29/25 | 2.04 on 10/28/25 | ||
| Latest Earnings Date | 02/18/26 | 02/25/26 | 02/11/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 18.12 | 33.25 | ||